Keaton Winn placed on 15-day IL with right elbow neuritis

The San Francisco Giants placed right-handed reliever Keaton Winn on the 15-day injured list retroactive to August 19, with right elbow neuritis, per Yahoo Sports. The move, made ahead of Thursday's day game against the Cleveland Guardians, marks Winn's second trip to the IL in 2026 and removes one of the few functional arms from a bullpen that has ranked among baseball's worst this season. Reiver Sanmartin was recalled to fill the roster spot.

What happened

Prior to the series finale against Cleveland, the Giants made the roster move. The retroactive date suggests the injury was identified or formally documented in the days leading up to the announcement, though the exact timeline of when Winn first experienced elbow soreness remains unclear. Yahoo Sports notes that it appears likely Winn has been dealing with elbow discomfort for some time, based on a sharp reduction in his usage—he was used just twice over a recent stretch—but the precise duration and severity remain unconfirmed.

Why it matters

Winn has been one of the few bright spots in San Francisco's bullpen this year—a low bar in a unit that has struggled significantly. Losing him, even temporarily, deepens the strain on a relief corps already stretched thin. The Giants are 59-85 (.410), 4th in the NL West and 27.5 games back, with the division race already decided. Their bullpen depth, already tested, now faces another gap.

The timing is particularly costly: the Giants head into a stretch that includes the day game at Cleveland on Thursday and then a series at Boston beginning Friday. A reliever of Winn's caliber—however modest his strikeout rate—is difficult to replace mid-season, especially for a team with limited margin for error in close games.

Right elbow neuritis refers to inflammation or irritation of the nerves in the elbow, a condition that can cause pain, numbness, or weakness. For a pitcher, the diagnosis typically requires rest and anti-inflammatory treatment, though the recovery timeline can vary depending on severity. The 15-day injured list is the standard placement for pitchers dealing with arm issues, allowing the club to evaluate whether the condition resolves within that window or requires a longer absence.

The numbers

In 44 appearances this season, Winn has posted a 3.35 ERA and a 3.85 FIP across 43 innings. He has struck out 33 batters. Those numbers, while not spectacular, represent relative stability in a bullpen that has been anything but. His FIP slightly exceeds his ERA, suggesting some luck in his favor, but the gap is narrow enough that his actual performance has been reasonably close to his underlying metrics.

The strikeout total—33 in 43 innings—reflects modest swing-and-miss rates, well below league average for relievers. But Winn has managed to limit damage through other means, keeping his ERA in the mid-threes despite the modest whiff rate. For a Giants bullpen that has struggled to find consistency, that kind of steady, if unspectacular, production has been valuable.

Where the club stands

The Giants enter Thursday's game against Cleveland with a record of 59-85 (.410), sitting in fourth place in the NL West, 27.5 games behind the division leader. They are ranked 11th in the Wild Card race, 17.0 games relative to the cut line, and have been eliminated from contention for the division title. The club is on a one-game losing streak heading into the day game at Progressive Field.

The schedule ahead offers little respite: after Cleveland, the Giants travel to Boston for a weekend series beginning Friday. Landen Roupp is the probable pitcher for Thursday against Gavin Williams. Logan Webb is slated to start Friday against Sonny Gray, followed by Blade Tidwell on Saturday against Patrick Sandoval.

With the postseason out of reach, the Giants are in evaluation mode, using the final weeks to assess which players fit into future plans and which roster spots remain open questions. Winn, despite his second IL stint, has shown enough this season to merit consideration as a bullpen piece going forward. His absence now, however, forces the club to lean on less-tested arms and see what Sanmartin and others can provide.

What we don't know yet

Yahoo Sports does not specify how long Winn is expected to remain sidelined or whether the elbow neuritis is expected to resolve within the standard 15-day window. The retroactive date gives the Giants a head start on the clock, meaning Winn could be eligible to return as soon as early September if the condition responds quickly to rest. But the lack of detail around severity leaves open the possibility of a longer absence.

It is also unclear whether Sanmartin, the recalled pitcher, will be used immediately or held in reserve, and what role he is expected to fill in the bullpen going forward. The Giants have not announced how they plan to redistribute Winn's innings or whether they will adjust their bullpen usage patterns in his absence.

What to watch

Watch Winn's status as the 15-day window progresses. If the elbow neuritis does not respond to rest, the Giants could move him to the 60-day IL, which would open a 40-man roster spot and signal a longer absence. The club has not indicated whether they expect him back this season or whether the injury could linger into the offseason.

Watch how Sanmartin is deployed in the coming days—whether he enters high-leverage situations or serves primarily as a depth option—to gauge the club's confidence in his readiness. The Giants' bullpen performance over the next week will also be telling. Without Winn, the relief corps will be tested heavily, particularly in close games. How the unit responds could influence whether the front office makes additional moves or focuses on development and evaluation as the season winds down.